This is the authors' abstract. We don't add key points for this paper.
Vaginal atrophy represents a frequently encountered condition which is significantly correlated with decreased amounts of circulating oestrogen levels. It is usually characterized by the presence of burning, itching, irritation and dyspareunia. In such cases attention was focused on identifying a topic product which might alleviate these symptoms and stop the deterioration process of the vaginal lining. One product which seems to have an effective role in order to stop this process and to offer a good local control of the disease should contain anti-inflammatory, healing and antiseptic principles. The aim of the current paper is to study the possible benefits of Cerviron a topic product with intravaginal administration which contains seven active principles in order to offer the above mentioned effects.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bacalbaşa et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: